Determining neurobiological factors that contribute to individual variance in drug addiction vulnerability allows for identification of at-risk populations, use of preventative measures and personalized medicine in the treatment of substance use disorders. Rodents that exhibit high locomotor activity when exploring an inescapable novel environment (high-responder; HR) are more susceptible to the reinforcing effects of many abused compounds, including nicotine, as compared to animals that exhibit low locomotor activity (low-responder; LR). Given that nicotinic acetylcholine receptor (nAChR) modulation of reward-related dopamine signaling at accumbal dopamine terminals is critical for the acquisition of drug selfadministration, we hypothesized that nAChR modulation of dopamine release would be predicted by an animal's novelty response. Using voltammetry in the nucleus accumbens core of rats, we found that nicotine produced opposite effects in HR and LR animals on stimulation frequencies that model phasic dopamine release, whereby release magnitude was either augmented or attenuated, respectively. Further, nicotine suppressed dopamine release elected by stimulation frequencies that model tonic release in LR animals, but had no effect in HR animals. The differential effects of nicotine were likely due to desensitization of nAChRs, since the nAChR antagonists mecamylamine (non-selective, 2 mM), dihydro-beta-erythroidine (b2-selective, 500 nM), and a-conotoxin MII [H9A; L15A] (a6-selective, 100 nM) produced effects similar to nicotine. Moreover, dihydro-beta-erythroidine failed to show differential effects in HR and LR rats when applied after a-conotoxin MII [H9A; L15A], suggesting a critical role of a6b2 compared non a6-containing nAChRs in the differential effects observed in these phenotypes. These results delineate a potential mechanism for individual variability in behavioral sensitivity to nicotine.
Introduction
Approximately twenty percent of individuals who have used drugs recreationally ultimately develop a substance use disorder (SAMHSA, 2008) . Therefore, the biological underpinnings of individual differences in the propensity to develop a substance use disorder have been an area of much interest and research. In preclinical rodent models, drug abuse vulnerability can be predicted by an animal's locomotor responsiveness to an inescapable novel environment. Indeed, animals with higher response to the novel environment (high-responder; HR) acquire drug selfadministration more rapidly and at lower doses than their lowresponder (LR) counterparts for many drugs of abuse, including psychostimulants such as cocaine and nicotine (Suto et al., 2001; Ferris et al., 2013a; Piazza et al., 1989) . Thus, the HR/LR model is a powerful tool for determining antecedent neurochemical characteristics that contribute to drug abuse vulnerability.
Dopamine cell firing in the ventral tegmental area (VTA) switches between tonic (single-spikes at 0.5e10 Hz with majority at 4e5 Hz) and phasic (2e5 spikes at ! 20 Hz) patterns to encode information concerning salient stimuli and the discrete and contextual cues that predict them (Waelti et al., 2001; Tobler et al., 2005; Marinelli and McCutcheon, 2014) . As a result, dopamine signaling in the nucleus accumbens (NAc) is critical in guiding organisms towards advantageous outcomes, and is necessary for acquisition of responding for both natural and drug reinforcers (Woolverton and Virus, 1989) . Dopamine release in the NAc is heavily modulated by nicotinic acetylcholine receptors (nAChR) located in both the VTA and directly on dopamine terminals in the NAc. nAChRs in the VTA are essential for nicotine reinforcement and nicotine-induced dopamine release in the NAc (Corrigall et al., 1994; Maskos et al., 2005) . Recent evidence suggests a critical role of a6 containing nAChR in the VTA in modulate dopamine release elicited by electrical stimulation of the VTA (Wickham et al., 2013) .
In the NAc, dopamine release is modulated by striatal cholinergic interneurons that signal through nAChRs. These interneurons exhibit decreased firing rates and corresponding decreases in acetylcholine release in a synchronous manner with dopamine neuron firing during salient environmental events (Morris et al., 2004) , but have also been shown to mediate an increase in acetylcholine overflow in the NAc core during acquisition of drug reinforcement (Crespo et al., 2006) . Cholinergic interneurons in the striatum can elicit dopamine release via a4b2 subunit containing nAChRs located on dopamine terminals in a manner that is independent of VTA dopamine neuron firing (Threlfell et al., 2012; Cachope et al., 2012) . Moreover, desensitization or pharmacological blockade of nAChRs in the NAc attenuates dopaminergic output at lower frequency electrical stimulations that model tonic firing, while either increasing or leaving unaffected, dopamine release at higher stimulation frequencies that model phasic firing (Rice and Cragg, 2004) . Indeed, nAChRs in the NAc are poised to dynamically modulate the range of dopaminergic influence on accumbal efferents (Zhang and Sulzer, 2004; Rice and Cragg, 2004) . nAChR blockade in the NAc prevents acquisition of drug selfadministration (Exley and Cragg, 2008a; Crespo et al., 2006; , but does not block nicotine self-administration once animals have been well trained (Corrigall et al., 1994) . Therefore, while VTA nAChRs are critical for nicotine reinforcement throughout all phases of nicotine self-administration, the interplay between cholinergic and dopaminergic signaling via nAChRs in the NAc core is critical for reward learning.
Given that nAChRs are integrally involved in modulating learning and reward-related dopamine neurotransmission, and that HR and LR animals vary greatly in reward learning and acquisition of drug self-administration, we hypothesized that nAChR modulation of dopamine signaling in the NAc would be predicted by the HR/LR phenotype. To address these questions we used ex vivo fast-scan cyclic voltammetry (FSCV) in the NAc core to measure dopamine release across a range of stimulation parameters in animals previously screened for their locomotor response to an inescapable novel environment. We then used various pharmacological manipulations to examine nAChR-modulation of dopamine release in these phenotypes.
Methods and materials

Animals
Male Sprague-Dawley rats (375e400 g, Harlan Laboratories, Frederick, Maryland) were maintained on a 12:12 h reverse light/ dark cycle (3:00 a.m. lights off; 3:00 p.m. lights on) with food and water ad libitum. All animals were maintained according to the National Institutes of Health guidelines in Association for Assessment and Accreditation of Laboratory Animal Care accredited facilities. The experimental protocol was approved by the Institutional Animal Care and Use Committee at Wake Forest School of Medicine.
Locomotor assessment
Animals were allowed seven days to acclimate to the housing environment and light cycle prior to the start of experiments. All locomotor testing occurred during the dark/active cycle (9:00AM). We avoided the light/inactive portion of the cycle to prevent sleep from contributing to variability (or lack thereof) in locomotor activity. Animals were first transferred to the locomotor testing room (lights off) and allowed to habituate within their home cages for 1 h. Animals were then placed in activity monitors (Med Associates, St. Albans, Vermont) and their horizontal activity was monitored for 90 min. The activity chambers were acrylic boxes measuring 43 Â 43 Â 30 cm and contained two infrared beam arrays. Horizontal activity was measured by beam breaks, which were recorded by a computer.
Ex vivo voltammetry
FSCV was used to characterize presynaptic dopamine release in the NAc core. Animals were sacrificed within one week, but no earlier than 24 h, after locomotor assessment. Animals were briefly anesthetized with isoflurane before decapitation was performed in a ventilated area free of any blood or tissue from previous animals.
A vibrating tissue slicer was used to prepare 400 mm thick coronal brain sections containing the NAc core as previously described (Siciliano et al., 2014) . We selected the NAc core given our interest in understanding individual differences in a brain region that is critical for conditioned learning and acquisition of drug selfadministration. The tissue was immersed in oxygenated artificial cerebrospinal fluid (aCSF) containing (in mM): NaCl (126), KCl (2.5), NaH 2 PO 4 (1.2), CaCl 2 (2.4), MgCl 2 (1.2), NaHCO 3 (25), glucose (11), Lascorbic acid (0.4) and pH was adjusted to 7.4. Once sliced, the tissue was transferred to the testing chambers containing bath aCSF (32 C), which flowed at 1 ml/min. A carbon fiber microelectrode (100e200 mM length, 7 mM diameter) and bipolar stimulating electrode were placed into the core of the NAc. Dopamine release was evoked by a single electrical pulse (750 mA, 2 msec, monophasic) applied to the tissue every 5 min. Extracellular dopamine was recorded by applying a triangular waveform (À0.4 to þ1.2 to À0.4 V vs Ag/AgCl, 400 V/s). Once the extracellular dopamine response was stable (3 collections within 10% variability), 5 pulse stimulations were applied to the slice with varying burst frequencies (5, 10, 20 or 100 Hz) in order to encompass the physiological range of dopamine neuron firing. (McIntosh et al., 2004) ) were bath applied and dopamine response to single pulse stimulation was allowed to equilibrate to the drug (3 collections within 10% variability). We targeted a6-containing nAChRs given their dominant role in mediating the effect of nicotine on dopamine release in the NAc (Exley et al., 2008b) . Separate slices were used in order to test each drug independently, and the same frequency-response curves assessed under drug-free conditions were reassessed following drug application in each slice. In a separate set of experiments, to test the independent contributions of a6 and non-a6 containing nAChRs, we repeated experiments described above and modified the procedure to add combinations of DhbE and a eCtx in a cumulative fashion, starting with application and equilibration of aCtx followed by DhbE. The difference in dopamine signaling across all frequencies between a-Ctx followed by a-Ctx þ DhbE isolates the contribution of (non-a6)a4b2-containing nAChRs. Notably, although a-Ctx can have off-target effects at a3 subunits, a-Ctx binding in NAc is a3 independent, confirming selectivity in this region (Whiteaker et al., 2002; Champtiaux et al., 2002) .
Data analysis
For all analysis of FSCV data Demon Voltammetry and Analysis software was used (Yorgason et al., 2011) . Recording electrodes were calibrated by recording responses (in electrical current; nA) to a known concentration of dopamine (3 mM) using a flow-injection system. This was used to convert electrical current to dopamine concentration. MichaeliseMenten modeling kinetics were used to determine maximal rate of dopamine uptake (Ferris et al., 2013b) .
Statistics
Bivariate regression (correlation) was the primary analysis used to assess the relationship between locomotor response to novelty and nAChR modulation of dopamine release. We performed a tertiary split of locomotor data (comparing top and bottom third of animals based on their locomotor data) in order to provide informative graphical representations of the effects of nAChR compounds on dopamine release. These groups were subject to a repeated measures two-way analysis of variance (ANOVA) with burst frequency as the within-subjects factor and group as the between-subjects factor. Differences between groups were tested using a Bonferroni post-hoc test.
Results
HR and LR animals do not differ in dopamine signaling
As expected, splitting animals into HR and LR groups revealed greater total distance traveled in HR animals (Fig. 1 inset; t 9 ¼ 5.298, p < 0.0005). We first sought to determine if locomotor activity predicted accumbal dopamine signaling across multiple frequencies. To examine the frequency dependence of dopamine signaling, dopamine was elicited by 5 pulse stimulations across the physiological range of dopamine neuron firing. Consistent with previous results (Ferris et al., 2013a) response to novelty did not predict dopamine release magnitude in response to single pulse stimulations ( Fig. 1B) 3.2. Response to novelty predicts nicotine effects on dopamine signals and locomotor response to systemic nicotine administration To determine the relationship between response to novelty and nAChR modulation of dopamine signaling, frequency-response curves were reassessed following bath application of nicotine (500 nM) ( Fig. 2A) . We found that there was no relationship between response to novelty and the effects of nicotine on dopamine release elicited by single pulse and low frequency stimulations (Fig. 2B ,C,D; 1 pulse: r ¼ 0.20, p ¼ 0.42; 5 Hz: r ¼ 0.38, p ¼ 0.12; 10 Hz: r ¼ 0.30, p ¼ 0.23). However, for higher frequency stimulations we found that response to novelty positively predicted dopamine release magnitude ( Fig. 2E and F; 20 Hz: r ¼ 0.57, p < 0.01; 100 Hz: r ¼ 0.59, p < 0.01). Splitting the data into HR and LR groups in Fig. 2G revealed that the dopamine release was affected with differential directionality between the two phenotypes. Nicotine facilitated the amplitude of phasic dopamine signaling without affecting tonic stimulations in HR animals while tonic and phasic signaling was suppressed in LR animals (phenotype (F (3, 24) ¼ 3.788, p ¼ 0.0235), frequency (F (4, 96) ¼ 55.04, p < 0.0001), interaction (F (12, 96) ¼ 4.444, p < 0.0001)). To explore whether response to novelty can predict behavioral outcome measures in response to nicotine, we assessed locomotor response to an acute, systemic injection of nicotine (0.4 mg/kg, s.c.) immediately following assessment of each animal's response to a novel environment in a separate set of animals (Fig. 3) . Total locomotor activity elicited by response to novelty significantly predicted locomotor response following a single systemic injection of nicotine (r ¼ 0.63, p < 0.01; Fig. 3A ). As expected, the acute injection of nicotine decreased locomotor activity in all animals (F (1, 10) ¼ 14.93, p < 0.01), but did so to a greater extend in LR animals compared to HR animals (F (1, 10) ¼ 9.4, p < 0.05) (Fig. 3B) . The difference between HR and LR animals response to nicotine is apparent when averaging locomotor activity (cm) that occurs within each of the 5 min bins across the session, and comparing pre-vs. post-nicotine in Fig. 3C . Indeed, only LR animals show a significant nicotine-induced decrease in locomotor activity compared to their own baseline (p < 0.05) in Fig. 3C , and when the effect of nicotine is normalized to each groups respective baseline in Fig. 3D (t 10 ¼ 1.95, p < 0.05).
nAChR blockade differentially modulates dopamine signaling between HR and LR animals
Having found that nicotine differentially modulated tonic and phasic dopamine release between HR and LR animals, we next determined if these effects could possibly be due to nicotineinduced desensitization of nAChR, rather than nicotine's actions as a nAChR agonist. Thus, we performed an identical experiment with the non-selective, non-competitive nAChR antagonist MEC (Fig. 4A) . We found that following bath application of MEC (2 mM), response to novelty positively predicted dopamine release at both tonic and phasic frequencies (Fig. 4B,C ,D,E,F; 1 pulse: r ¼ 0.67, p < 0.01; 5 Hz: 0.71, p < 0.009; 10 Hz: r ¼ 0.80, p < 0.002; 20 Hz: r ¼ 0.75, p < 0.003; 100 Hz: r ¼ 0.77, p < 0.0001). In agreement with the effects of nicotine, MEC differentially affected tonic and phasic dopamine signaling between HR and LR animals whereby release elicited by high frequency stimulations was increased in HR animals and decreased in LR animals (Fig. 4G; phenotype (F (3, 14) ¼ 2.579, p ¼ 0.0951), frequency (F (4, 56) ¼ 48.44, p < 0.0001), interaction (F (12, 56) ¼ 6.161, p < 0.0001)). 
a6b2-containing nAChRs differentially modulate dopamine signaling between HR and LR animals
To further determine differences in nAChR modulation of tonic and phasic dopamine signaling between HR and LR animals we examined the effects of DhbE, an antagonist selective for b2 subunit containing nAChRs (Fig. 5A) . Following bath application of DhbE (500 nM), we found no relationship between response to novelty and dopamine release elicited by tonic stimulation frequencies (Fig. 5B ,C,D; 1 pulse: r ¼ 0.60, p ¼ 0.12; 5 Hz: r ¼ 0.39, p ¼ 0.33; 10 Hz r ¼ 0.43, p ¼ 0.29). Similar to the effects of nicotine on dopamine release, we found a positive relationship between response to novelty and the effects of DhbE on phasic dopamine release ( Fig. 5E and F; 20 Hz: r ¼ 0.80, p < 0.02; 100 Hz: r ¼ 0.91, p < 0.002). Indeed, DhbE differentially effected phasic dopamine release between HR and LR animals whereby phasic signaling was amplified in HR animals and unaffected in LR animals ( Fig. 5G ; phenotype (F (3, 12) ¼ 5.678, p ¼ 0.0117), frequency (F (4, 48) ¼ 140.4, p < 0.0001), interaction (F (12, 48) ¼ 17.26, p < 0.0001)).
To further localize the differential effects of nicotine between HR and LR animals, we examined the effects of the a6 nAChR selective toxin a-Ctx (Fig. 6A ). a6-containing nAChR subunits are the primary mediators of nicotine's effect on dopamine release in the NAc (Exley et al., 2008b) . Bath application of a-Ctx (100 nM) revealed no relationship between the effects of a6 nAChR blockade on dopamine release elicited by tonic stimulations (Fig. 6B,C There is variation (albeit nonsignificant) in the extent of modulation of dopamine release for both low and high stimulations between DhbE and a-Ctx (e.g., Fig. 5F vs 6F) . Therefore, we bath applied a-Ctx first followed by DhbE in order to assess and confirm the relative contribution of both a6 and non-a6 subunits to individual differences in dopamine release. When DhbE is applied to slices after a-Ctx is applied and equilibrated, dopamine release magnitude is further modulated, but equally so in HR and LR animals (Fig. 7) . DhbE when applied in the presence of a-Ctx causes an equal, non-significant trend toward reduced dopamine release to low frequencies with restoration of release at high frequencies in both HR and LR animals (Fig. 7AeD) . Additionally, the relationship between locomotor activity and relative shifts in dopamine release magnitude that is observed for DHbE without a-Ctx (Fig. 5) is no longer present with DhbE is applied after a-Ctx (Fig. 7B and C) .
Therefore, non-a6 nAChRs may modulate dopamine release above and beyond a6-containing nAChRs to some degree, but only the a6-containing nAChRs are responsible for differential effects observed in HR and LR animals. To ensure that these effects were not due to off-target drug action or extended duration of the experiment, in a separate slice, we ran a control experiment in which these same drugs were applied in the opposite order (DhbE followed by a-Ctx). As expected, there was no additional effect of a-Ctx in this case (data not shown). 
Discussion
We show that response to novelty can predict nAChR modulation of dopamine signaling in the ventral striatum. Specifically, dopamine release magnitude following multiple pulse stimulations !20 Hz was positively correlated with locomotor response to novelty, but only while in the presence of nicotine, MEC, DhbE, or aCtx. Blockade of nAChR amplifies phasic dopamine release in HR animals and inhibits phasic dopamine release in LR animals. Further, we demonstrated that these opposing effects are likely attributed to a6b2-subunit containing nAChRs. The involvement of a6b2 is consistent with reports demonstrating that a6 subunits dominate dopamine release dynamics in the ventromedial striatum (Exley et al., 2008b) . Moreover, response to novelty also predicted the degree of locomotor depression caused by acute administration of nicotine. These results demonstrate that nAChR modulation of dopamine release varies substantially across individuals and provides a potential mechanism for differential behavioral sensitivity to nicotine as well as augmented drug abuse vulnerability and general learning ability in HR animals (Suto et al., 2001; Piazza et al., 1989; Matzel et al., 2006) .
The disparities between HR and LR animals observed here are likely to have implications for both general and drug reinforcement learning because endogenous cholinergic signaling in the striatum is instrumental in modulating dopamine signals that underlie these behaviors (Cachope et al., 2012; Exley and Cragg, 2008a ). For example, burst firing and pauses in acetylcholine interneuron activity, which occur sequentially in response to salient environmental cues, can elicit dopamine release directly or modulate the magnitude of action-potential dependent dopamine release, respectively. The magnitude of these rapid dopamine signals influences both learning of associations between primary rewards and their predictors, as well as motivation/incentive salience induced by reward predictive cues (Beyene et al., 2010; Flagel et al., 2011) . Indeed, nAChR signaling in the striatum is required for acquisition of drug self-administration as well as procedural learning for non-drug reinforcers, and it is thought that these effects are primarily mediated through interactions with dopaminergic signaling (Kitabatake et al., 2003; Exley and Cragg, 2008; Crespo et al., 2006) . nAChRs located directly on dopamine terminals are in an ideal position to influence acquisition of drug selfadministration and reinforcement learning. Previous work has shown that nAChRs in VTA and NAc appear to have modulatory actions on phasic dopamine signaling, as micro-infusions of MEC into the VTA attenuates (Wickham et al., 2013) while MEC into the NAc augments (Collins et al., 2016) NAc dopamine signaling in vivo. While previous literature has highlighted the importance of cholinergic signaling in both VTA and NAc to learning and reinforcement, here we show that accumbal nAChRs display wide individual variations in regard to modulation of axonal dopamine release.
We show here that signaling via nAChRs modulates the magnitude of phasic dopamine signals in an opposite manner in animals with differential response to novelty, which serves as a model for initiation of drug use (e.g., drug use prone vs resistant). Therefore, the current finding that nAChRs differentially modulate dopamine signals important for learning and motivation may provide a putative mechanism for the fact that HR animals not only acquire self-administration of many drugs of abuse faster than their LR counterparts (Ferris et al., 2013a; Piazza et al., 1989 ), but also have been shown to have better performance on general learning tasks (Matzel et al., 2006) . Moreover, it suggests a possibility for how nicotine use, via facilitation of reward-related dopamine signals in a specific population, could subsequently facilitate dopamine signals necessary for developing associations between rewards and their predictors, ultimately leading to increased vulnerability to abuse other illicit substances (Picciotto et al., 2008) . Dopamine signals in the NAc core are essential for learned associations between rewards and their predictors and this study as well as work from many others have highlighted the powerful modulatory role of local nAChRs on dopamine signaling. To explore the possibility that HR and LR phenotypes may display differential behavioral sensitivity to nicotine, we examined the effects of acute injection of nicotine on locomotion. We found that LR animals displayed greater sensitivity to the locomotor attenuating effects of acutely administered nicotine. Dopamine driven changes in locomotor activity are thought to rely more on sustained alterations in tonic levels of extracellular dopamine (Giros et al., 1996; Jones et al., 1999; Rao et al., 2013) , as opposed to subsecond phasic signals that are essential for learning. The Response to novelty did not predict the effects of a-Ctx (100 nM) on dopamine release elicited by a single pulse, 5 Hz or 10 Hz stimulations. However we found that response to novelty positively predicted the effects of a6 subunit containing nAChR blockade on dopamine release elicited by 20 Hz (E) and 100 Hz (F) stimulations. (G) a-Ctx augments phasic dopamine release in HR animals and while suppressing release in LR animals. #p < 0.05 LR þ a-Ctx vs HR þ a-Ctx; ##, p < 0.01LR þ a-Ctx vs HR þ a-Ctx. N (number of rats) ¼ 11.
augmented sensitivity to nicotine-induced depression of locomotor activity in LR rats is consistent with the increased sensitivity of LRs to nicotine-induced depression of in dopamine release elicited by tonic-like frequencies. The relationships between locomotor response to novelty, nicotine, and nAChR modulation of dopamine release is consistent with previous work showing genetic modulation of either b2-or a6-containing nAChRs can govern dopamineinduced locomotor response to novelty (Villegier et al., 2010; Cohen et al., 2012) . It is unclear, however, the extent to which individual differences in response to novelty or accumbal nAChR modulation of phasic dopamine signals would predict differences in the reinforcing aspects of nicotine. HR animals have been shown to acquire nicotine self-administration more rapidly and display increased motivation to obtain nicotine as measured by greater responding during a progressive ratio schedule of reinforcement (Suto et al., 2001 ). However, studies have shown that nAChRs in the NAc core possess little to no role in maintaining nicotine reinforcement in animals well-trained for nicotine self-administration (Corrigall et al., 1994; Maskos et al., 2005) . Moreover, dopamine signaling in the NAc core, regardless of its modulation by nAChRs, has been shown to play less of a role in well-learned behavior as the locus of activity shifts from ventral striatum during goal directed behavior to more dorsal striatal regions during habitual and compulsive behavior (Everitt and Robbins, 2005; Porrino et al., 2007; Willuhn et al., 2012) . Consistent with the dichotomy in the role of accumbal nAChRs and dopamine in learning versus well-trained behavior is the fact that variability in the locomotor response to novelty can predict acquisition of many drugs of abuse (Ferris et al., 2013a; Piazza et al., 1989) , but is less able to predict measures of maintenance of drug self-administration in well trained animals (Belin et al., 2011) .
While dopamine signaling in HR and LR animals was differentially modulated by nicotine, we further elucidated that these effects were likely due to desensitization of nAChRs, since blockade of nAChRs with either MEC, DHbE, or a-Ctx produced nearly identical effects to nicotine. A single cigarette is sufficient to desensitize nAChRs in humans (Brody et al., 2006) . Thus, these results provide a potential mechanism for increased subjective effects of nicotine in humans that are scored high in measures of sensation seeking (Perkins et al., 2000) , particularly since this trait in humans is modeled in rodents by their locomotor response to novelty (Dellu et al., 1996) .
In addition to the differential nAChR modulation of axonal dopamine release between HR and LR animals shown here, previous reports have demonstrated that HR animals also display a greater influence of nAChRs on excitatory synaptic inputs onto VTA dopamine neurons, as well as directly on the dopamine cell bodies (Fagen et al., 2007) . While our study is consistent with the Fagen et al. (2007) study, it is important to note that our approach of measuring dopamine release in NAc dopamine terminals using voltammetry is fundamentally different than measuring VTA cell firing. We hold firing constant in our studies since we apply . After a-Ctx effects stabilized, DhbE was added to the slice (dashed lines); any additional effects of DhbE after a-Ctx-induced a6 subunit containing nAChR blockade are presumed to be due to non-a6b2 subunit containing nAChRs. Following bath application of DhbE response to novelty did not correlate with dopamine release for tonic (B) or phasic (C) stimulations. (D) DhbE modulates dopamine release after a6 subunit containing nAChR are blocked, however, the effect does not differ between HR and LR animals. N (number of rats) ¼ 6. exogenous electrical stimulation using the same number of pulses at the same frequency across all of our animals. Thus, we are studying two very different biological functions having controlled for (i.e., eliminated) variance that served as the primary observation for the Fagen et al. (2007) study. In other words, while we are studying the same phenotype, we are investigating a very different outcome measures (release vs firing) and have demonstrated individual differences in the ability of nAChRs to modulate dopamine release magnitude while holding firing frequency constant. Therefore, the current findings give novel insight into the neurobiological variations that underlie individual differences in learning and suggest a common mechanism in meditating susceptibility to abused compounds. Moreover, we postulate that HR animals display augmentation of reward-related dopamine signaling (Flagel et al., 2011) through differences in nAChR function in both the cell body (Fagen et al., 2007) and terminal regions (current study) of the mesolimbic dopamine system. Smoking cessation treatments that target nAChRs have been shown to engender wide individual variability in treatment outcomes (Russo et al., 2011) . The current findings may inform personalization of pharmacotherapeutic interventions, perhaps based on measures of sensation seeking, and could also lead to novel therapeutic approaches to learning deficits in other neuropsychiatric disorders.
